These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8857911)

  • 21. Lidocaine metabolite formation as a measure of perioperative liver function.
    Shimanuki K; Sakurabayashi I; Miyata M; Kiyozaki H; Suzuki W; Kashii A; Seo N
    Surg Today; 1993; 23(4):315-9. PubMed ID: 8318785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of lidocaine as a test of liver function in liver transplantation.
    Potter JM; Oellerich M
    Liver Transpl Surg; 1996 May; 2(3):211-24. PubMed ID: 9346651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEGX as a test of donor liver function.
    Balderson GA; Potter JM; Hickman PE; Chen Y; Lynch SV; Strong RW
    Transplant Proc; 1992 Oct; 24(5):1960-1. PubMed ID: 1412928
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of lidocaine metabolite (monoethylglycinexylidide) as a liver function test].
    Shimanuki K; Suzuki W; Sakurabayashi I; Kiyozaki H; Shinohara K; Soda K; Kai T; Satake M; Miyata M
    Nihon Shokakibyo Gakkai Zasshi; 1993 Jan; 90(1):33-40. PubMed ID: 8433534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates.
    Burdelski M; Schütz E; Nolte-Buchholtz S; Armstrong VW; Oellerich M
    Ther Drug Monit; 1996 Aug; 18(4):378-82. PubMed ID: 8857554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of monoethylglycinexylidide as a liver function test in the liver transplant recipient.
    Potter JM; Hickman PE; Lynch SV; Henderson A; Wright M; Balderson G; Strong RW
    Transplantation; 1993 Dec; 56(6):1385-8. PubMed ID: 8279008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The validity of the MEGX test in correlation with histology after orthotopic rat liver transplantation.
    Keck H; Bachmann S; Knoop M; Dobis C; Meyer A; Neuhaus P
    Transpl Int; 1994; 7 Suppl 1():S208-12. PubMed ID: 11271204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological comparison of donor livers and lidocaine metabolism in the utilization of organs for liver transplantation.
    Rosenlof LK; Sawyer RG; Broccoli AV; Ishitani MB; Stevenson WC; Pruett TL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1662-3. PubMed ID: 8442229
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
    Shiffman ML; Luketic VA; Sanyal AJ; Thompson EB
    Ther Drug Monit; 1996 Aug; 18(4):372-7. PubMed ID: 8857553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs.
    Neumann S; Frenz M; Streit F; Oellerich M
    Can J Vet Res; 2011 Oct; 75(4):317-20. PubMed ID: 22468031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lignocaine metabolism and MEGX production in the liver transplant donor.
    Potter JM; Hickman PE; Balderson G; Lynch SV; Strong R
    Transplant Proc; 1992 Feb; 24(1):198-9. PubMed ID: 1539243
    [No Abstract]   [Full Text] [Related]  

  • 33. Lignocaine metabolism and liver function testing in primary graft failure following orthotopic liver transplantation.
    Potter JM; Wright M; Lynch SV; Strong RW; Henderson A; Balderson G; Walker NI; Hickman PE
    Med J Aust; 1993 Jan; 158(2):125-6. PubMed ID: 8419755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
    Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
    Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoethylglycinexylidide (MEGX)-test. A test for the assessment of prognosis before and after liver transplantation].
    Reichel C; Wienkoop G; Nacke A; Spengler U
    Dtsch Med Wochenschr; 1995 Feb; 120(6):179-83. PubMed ID: 7851289
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of MEGX (monoethylglycinexylidide) and antipyrine tests in patients with liver cirrhosis.
    Wojcicki J; Kozlowski K; Drozdzik M; Wojcicki M
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):243-7. PubMed ID: 12587953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
    Bhise SB; Dias RJ
    Indian J Gastroenterol; 2007; 26(4):167-9. PubMed ID: 17986743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of the donor MEGX test in predicting liver allograft recipient outcome.
    Potter JM; Balderson GA; Hickman PE; Henderson A; Wright M; Burrow B; Lynch SV; Ong TH; Strong RW
    Transplantation; 1994 Aug; 58(4):524-6. PubMed ID: 8073525
    [No Abstract]   [Full Text] [Related]  

  • 39. Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosis?
    Testa R; Valente U; Risso D; Caglieris S; Giannini E; Fasoli A; Botta F; Dardano G; Lantieri PB; Celle G
    Eur J Gastroenterol Hepatol; 1999 May; 11(5):559-63. PubMed ID: 10755262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study.
    Addario L; Scaglione G; Tritto G; Di Costanzo GG; De Luca M; Lampasi F; Galeota Lanza A; Picciotto FP; Tartaglione MT; Utech W; Macr M; Giannelli E; Ascione A
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):713-20. PubMed ID: 16772827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.